Author

H. Zhang

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Inflammatory indices significantly improve one-year mortality prediction in STEMI patients: a large-scale multi-center study

Inflammation is crucial to the pathogenesis, progression, and prognosis of ST-segment elevation myocardial infarction (STEMI). Routine complete blood count-derived inflammatory indices—neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), and monocyte-...

Fang-Jie Ji, J. Liu, R. Guo et al. · European Heart Journal · 0 citations

Open access Oct 2026

One-year clinical outcomes of aspirin versus indobufen in patients with NSTEMI: a multicenter retrospective cohort study

Aspirin is the cornerstone of antiplatelet therapy for non-ST-elevation myocardial infarction (NSTEMI), while indobufen serves as an alternative for patients with aspirin intolerance. However, comparative data on their long-term efficacy and safety in real-world NSTEMI populations are limited. This study a...

H. Zhang, S.-T. Hu, R. Guo et al. · European Heart Journal · 0 citations

Open access Oct 2026

LDL-c levels and clinical outcomes in acute myocardial infarction patients with prior ischemic stroke

The optimal low-density lipoprotein cholesterol (LDL-c) target after acute myocardial infarction (AMI) in patients with prior ischemic stroke remains uncertain, particularly regarding the trade-off between ischemic protection and bleeding risk. We evaluated the association between LDL-c levels achieved at three m...

Y.-K. Zhang, R. Guo, Z. Xue et al. · European Heart Journal · 0 citations